Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 02-2017 | 02-2016 | |
| Sales | 0 | 0 | 0 | 0 | 29 |
| Cost of Goods | N/A | N/A | N/A | N/A | 63 |
| Gross Profit | N/A | N/A | N/A | N/A | -34 |
| Operating Expenses | 24,438 | 34,406 | 15,367 | 8,001 | 7,403 |
| Operating Income | -24,438 | -34,406 | -15,367 | -8,001 | -7,374 |
| Interest Expense | 1,075 | 4,960 | 1,142 | 64 | 2 |
| Other Income | 0 | 0 | -268 | -24 | 2,529 |
| Pre-tax Income | -25,513 | -39,366 | -16,777 | -8,089 | -4,846 |
| Income Tax | N/A | N/A | N/A | -98 | N/A |
| Net Income Continuous | -25,513 | -39,366 | -16,777 | -7,991 | -4,846 |
| Net Income | $-25,513 | $-39,366 | $-16,777 | $-7,991 | $-4,846 |
| EPS Basic Total Ops | -14.40 | -35.03 | -46.05 | -35.50 | -21.74 |
| EPS Basic Continuous Ops | -14.48 | -34.80 | -46.04 | -35.55 | -21.82 |
| EPS Diluted Total Ops | -14.40 | -35.03 | -46.05 | -35.50 | -21.74 |
| EPS Diluted Continuous Ops | -14.48 | -34.80 | -46.04 | -35.55 | -21.82 |
| EPS Diluted Before Non-Recurring Items | -11.04 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-22,118 | $-32,073 | $-13,282 | $-6,086 | $-5,537 |